French Cohort of Myocardial Infarction Evaluation
Assistance Publique - Hôpitaux de Paris
30,000 participants
Mar 11, 2019
OBSERVATIONAL
Conditions
Summary
Over the last two decades, considerable progress has been made in the management of Acute Myocardial Infarction (AMI), both in the acute phase and in monitoring beyond the hospital phase. Nevertheless, the evolution of care practices and their impact on the mid- and long-term prognosis of patients admitted to the intensive care unit for acute myocardial infarction remain relatively little studied exhaustively. The aim of this study is to assess the profile of AMI patients, their management and follow-up in order to evaluate the relationship between these factors and outcomes.
Eligibility
Inclusion Criteria6
- Myocardial infarction (MI) within 48h of symptom onset, characterized by the typical increased or fall of troponin (or CPKMB) associated with at least one of the following elements :
- Symptoms compatible with myocardial ischemia
- Appearance of pathological Q waves
- ST- T changes compatible with myocardial ischemia (ST segment elevation or depression, T-wave inversion)
- Written consent.
- Covered by French medical insurance ("Sécurité Sociale")
Exclusion Criteria2
- Iatrogenic MI defined as MI occurring within 48h of a therapeutic procedure
- AMI diagnosis invalidated in favor of another diagnosis
Interested in this trial?
Get notified about updates and connect with the research team.
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT04050956